ID PA213_AUSSU Reviewed; 146 AA. AC Q9PUH1; DT 01-NOV-2002, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2000, sequence version 1. DT 25-NOV-2008, entry version 46. DE RecName: Full=Phospholipase A2 isozyme S14-72F; DE EC=3.1.1.4; DE AltName: Full=Phosphatidylcholine 2-acylhydrolase; DE AltName: Full=ASPLA13; DE Flags: Precursor; OS Austrelaps superbus (Australian copperhead). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Lepidosauria; Squamata; Scleroglossa; Serpentes; Colubroidea; OC Elapidae; Acanthophiinae; Austrelaps. OX NCBI_TaxID=29156; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Venom gland; RX MEDLINE=20166950; PubMed=10700385; DOI=10.1006/abbi.1999.1672; RA Singh S.B., Armugam A., Kini R.M., Jeyaseelan K.; RT "Phospholipase A(2) with platelet aggregation inhibitor activity from RT Austrelaps superbus venom: protein purification and cDNA cloning."; RL Arch. Biochem. Biophys. 375:289-303(2000). CC -!- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2- CC acyl groups in 3-sn-phosphoglycerides. Inhibits collagen-induced CC platelet aggregation (By similarity). CC -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1- CC acylglycerophosphocholine + a carboxylate. CC -!- COFACTOR: Calcium (Probable). CC -!- SUBCELLULAR LOCATION: Secreted (By similarity). CC -!- TISSUE SPECIFICITY: Expressed by the venom gland. CC -!- SIMILARITY: Belongs to the phospholipase A2 family. Group I CC subfamily. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF184139; AAD56562.1; -; mRNA. DR HSSP; P00608; 1AE7. DR SMR; Q9PUH1; 28-146. DR HOVERGEN; Q9PUH1; -. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro. DR GO; GO:0016042; P:lipid catabolic process; IEA:InterPro. DR GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW. DR GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro. DR InterPro; IPR016090; Phospholipase_A2. DR InterPro; IPR013090; Phospholipase_A2_AS. DR InterPro; IPR001211; Phospholipase_A2_euk. DR Gene3D; G3DSA:1.20.90.10; Phospholipase_A2; 1. DR PANTHER; PTHR11716; Phospholipase_A2; 1. DR Pfam; PF00068; Phospholip_A2_1; 1. DR PRINTS; PR00389; PHPHLIPASEA2. DR ProDom; PD000303; PhospholipaseA2; 1. DR SMART; SM00085; PA2c; 1. DR PROSITE; PS00119; PA2_ASP; 1. DR PROSITE; PS00118; PA2_HIS; 1. PE 2: Evidence at transcript level; KW Calcium; Hydrolase; Lipid degradation; Metal-binding; Secreted; KW Signal; Toxin. FT SIGNAL 1 19 Potential. FT PROPEP 20 27 Potential. FT /FTId=PRO_0000022809. FT CHAIN 28 146 Phospholipase A2 isozyme S14-72F. FT /FTId=PRO_0000022810. FT ACT_SITE 75 75 By similarity. FT ACT_SITE 120 120 By similarity. FT METAL 55 55 Calcium; via carbonyl oxygen (By FT similarity). FT METAL 57 57 Calcium; via carbonyl oxygen (By FT similarity). FT METAL 59 59 Calcium; via carbonyl oxygen (By FT similarity). FT METAL 76 76 Calcium (By similarity). FT DISULFID 38 98 By similarity. FT DISULFID 54 145 By similarity. FT DISULFID 56 72 By similarity. FT DISULFID 71 126 By similarity. FT DISULFID 78 119 By similarity. FT DISULFID 87 112 By similarity. FT DISULFID 105 117 By similarity. SQ SEQUENCE 146 AA; 16280 MW; CABA49837A25186B CRC64; MYPAHLLVLL AVCVSLLGAA SIPPQPLNLV QFSYLIQCAN HGSRATWHYT DYGCYCGSGG SGTPVDELDR CCQTHDNCYG EAEKKGCYPK MLAYDYYCGG DGPYCRNIKK ECQRFVCDCD VEAAKCFARA PYNDANWNID TKKRCQ //